rs5400

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000340.2(SLC2A2):​c.329C>T​(p.Thr110Ile) variant causes a missense change. The variant allele was found at a frequency of 0.143 in 1,613,530 control chromosomes in the GnomAD database, including 21,251 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 5454 hom., cov: 32)
Exomes 𝑓: 0.13 ( 15797 hom. )

Consequence

SLC2A2
NM_000340.2 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 7.13

Publications

97 publications found
Variant links:
Genes affected
SLC2A2 (HGNC:11006): (solute carrier family 2 member 2) This gene encodes an integral plasma membrane glycoprotein of the liver, islet beta cells, intestine, and kidney epithelium. The encoded protein mediates facilitated bidirectional glucose transport. Because of its low affinity for glucose, it has been suggested as a glucose sensor. Mutations in this gene are associated with susceptibility to diseases, including Fanconi-Bickel syndrome and noninsulin-dependent diabetes mellitus (NIDDM). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]
SLC2A2 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to GLUT2 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, G2P
  • neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • permanent neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • transient neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002820909).
BP6
Variant 3-171014511-G-A is Benign according to our data. Variant chr3-171014511-G-A is described in ClinVar as Benign. ClinVar VariationId is 130349.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.452 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC2A2NM_000340.2 linkc.329C>T p.Thr110Ile missense_variant Exon 3 of 11 ENST00000314251.8 NP_000331.1 P11168-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC2A2ENST00000314251.8 linkc.329C>T p.Thr110Ile missense_variant Exon 3 of 11 1 NM_000340.2 ENSP00000323568.3 P11168-1

Frequencies

GnomAD3 genomes
AF:
0.222
AC:
33796
AN:
151980
Hom.:
5439
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.458
Gnomad AMI
AF:
0.0757
Gnomad AMR
AF:
0.178
Gnomad ASJ
AF:
0.143
Gnomad EAS
AF:
0.00925
Gnomad SAS
AF:
0.150
Gnomad FIN
AF:
0.129
Gnomad MID
AF:
0.142
Gnomad NFE
AF:
0.132
Gnomad OTH
AF:
0.205
GnomAD2 exomes
AF:
0.147
AC:
36820
AN:
251322
AF XY:
0.144
show subpopulations
Gnomad AFR exome
AF:
0.461
Gnomad AMR exome
AF:
0.117
Gnomad ASJ exome
AF:
0.138
Gnomad EAS exome
AF:
0.00555
Gnomad FIN exome
AF:
0.131
Gnomad NFE exome
AF:
0.134
Gnomad OTH exome
AF:
0.147
GnomAD4 exome
AF:
0.135
AC:
196835
AN:
1461432
Hom.:
15797
Cov.:
33
AF XY:
0.135
AC XY:
98005
AN XY:
727040
show subpopulations
African (AFR)
AF:
0.464
AC:
15525
AN:
33462
American (AMR)
AF:
0.124
AC:
5537
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.140
AC:
3649
AN:
26134
East Asian (EAS)
AF:
0.0143
AC:
567
AN:
39696
South Asian (SAS)
AF:
0.153
AC:
13205
AN:
86246
European-Finnish (FIN)
AF:
0.133
AC:
7115
AN:
53418
Middle Eastern (MID)
AF:
0.166
AC:
960
AN:
5768
European-Non Finnish (NFE)
AF:
0.127
AC:
141437
AN:
1111604
Other (OTH)
AF:
0.146
AC:
8840
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
8799
17598
26398
35197
43996
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5186
10372
15558
20744
25930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.223
AC:
33852
AN:
152098
Hom.:
5454
Cov.:
32
AF XY:
0.220
AC XY:
16398
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.458
AC:
18982
AN:
41450
American (AMR)
AF:
0.177
AC:
2711
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.143
AC:
495
AN:
3470
East Asian (EAS)
AF:
0.00927
AC:
48
AN:
5176
South Asian (SAS)
AF:
0.150
AC:
725
AN:
4826
European-Finnish (FIN)
AF:
0.129
AC:
1363
AN:
10594
Middle Eastern (MID)
AF:
0.139
AC:
41
AN:
294
European-Non Finnish (NFE)
AF:
0.132
AC:
8984
AN:
67986
Other (OTH)
AF:
0.206
AC:
434
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1202
2405
3607
4810
6012
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
324
648
972
1296
1620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.162
Hom.:
10738
Bravo
AF:
0.234
TwinsUK
AF:
0.129
AC:
477
ALSPAC
AF:
0.127
AC:
489
ESP6500AA
AF:
0.447
AC:
1970
ESP6500EA
AF:
0.133
AC:
1147
ExAC
AF:
0.154
AC:
18691
Asia WGS
AF:
0.110
AC:
387
AN:
3478
EpiCase
AF:
0.142
EpiControl
AF:
0.142

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Dec 14, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Fanconi-Bickel syndrome Benign:3
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Oct 22, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.041
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
17
DANN
Benign
0.16
DEOGEN2
Benign
0.25
T
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.39
FATHMM_MKL
Benign
0.093
N
LIST_S2
Benign
0.61
T
MetaRNN
Benign
0.0028
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-2.7
N
PhyloP100
7.1
PrimateAI
Benign
0.48
T
PROVEAN
Benign
3.4
N
REVEL
Benign
0.17
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.023
MPC
0.15
ClinPred
0.018
T
GERP RS
6.1
Varity_R
0.044
gMVP
0.22
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5400; hg19: chr3-170732300; COSMIC: COSV58585841; API